title: Child-Parent Familial Hypercholesterolemia Screening in Primary Care.
abstract: Child-parent screening for familial hypercholesterolemia has been proposed to identify persons at high risk for inherited premature cardiovascular disease. We assessed the efficacy and feasibility of such screening in primary care practice.
  
  
  
  We obtained capillary blood samples to measure cholesterol levels and to test for familial hypercholesterolemia mutations in 10,095 children 1 to 2 years of age during routine immunization visits. Children were considered to have positive screening results for familial hypercholesterolemia if their cholesterol level was elevated and they had either a familial hypercholesterolemia mutation or a repeat elevated cholesterol level 3 months later. A parent of each child with a positive screening result for familial hypercholesterolemia was considered to have a positive screening result for familial hypercholesterolemia if he or she had the same mutation as the child or, if no mutations were identified, had the higher cholesterol level of the two parents.
  
  
  
  The use of a prespecified cholesterol cutoff value of 1.53 multiples of the median (MoM, corresponding to a percentile of 99.2) identified 28 children who had positive screening results for familial hypercholesterolemia (0.3% of the 10,095 children; 95% confidence interval [CI], 0.2 to 0.4), including 20 with a familial hypercholesterolemia mutation and 8 with a repeat cholesterol level of at least 1.53 MoM. A total of 17 children who had a cholesterol level of less than 1.53 MoM also had a familial hypercholesterolemia mutation. The overall mutation prevalence was 1 in 273 children (37 in 10,095; 95% CI, 1 in 198 to 1 in 388). The use of an initial cholesterol cutoff value of 1.35 MoM (95th percentile) plus a mutation, or two cholesterol values of at least 1.50 MoM (99th percentile), identified 40 children who had positive screening results for familial hypercholesterolemia (0.4% of the 10,095 children, including 32 children who had a familial hypercholesterolemia mutation and 8 who did not have the mutation) and 40 parents who had positive screening results for familial hypercholesterolemia.
  
  
  
  Child-parent screening was feasible in primary care practices at routine child immunization visits. For every 1000 children screened, 8 persons (4 children and 4 parents) were identified as having positive screening results for familial hypercholesterolemia and were consequently at high risk for cardiovascular disease. (Funded by the Medical Research Council.).
authors: From the Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (D.S.W., J.P.B., J.K.M., K.W., N.J.W.), and the North East Thames Molecular Genetics Laboratory, Great Ormond Street Hospital (L.J.) - all in London.
authors: David S
authors: DS
authors: Wald
authors: From the Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (D.S.W., J.P.B., J.K.M., K.W., N.J.W.), and the North East Thames Molecular Genetics Laboratory, Great Ormond Street Hospital (L.J.) - all in London.
authors: Jonathan P
authors: JP
authors: Bestwick
authors: From the Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (D.S.W., J.P.B., J.K.M., K.W., N.J.W.), and the North East Thames Molecular Genetics Laboratory, Great Ormond Street Hospital (L.J.) - all in London.
authors: Joan K
authors: JK
authors: Morris
authors: From the Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (D.S.W., J.P.B., J.K.M., K.W., N.J.W.), and the North East Thames Molecular Genetics Laboratory, Great Ormond Street Hospital (L.J.) - all in London.
authors: Ken
authors: K
authors: Whyte
authors: From the Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (D.S.W., J.P.B., J.K.M., K.W., N.J.W.), and the North East Thames Molecular Genetics Laboratory, Great Ormond Street Hospital (L.J.) - all in London.
authors: Lucy
authors: L
authors: Jenkins
authors: From the Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (D.S.W., J.P.B., J.K.M., K.W., N.J.W.), and the North East Thames Molecular Genetics Laboratory, Great Ormond Street Hospital (L.J.) - all in London.
authors: Nicholas J
authors: NJ
authors: Wald
mesh_terms: D000328:Adult; D002675:Child, Preschool; D002784:Cholesterol / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D007223:Infant; D008297:Male; D008403:Mass Screening; D009154:Mutation; D010290:Parents; D011314:Preventive Health Services; D011320:Primary Health Care
chemical_list: D008078:Cholesterol, LDL; D002784:Cholesterol